Seymour June Ann

Seymour June Ann is listed in filings as Chief Accounting Officer at Cartesian Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 6, 2026, including 3 public disclosures. Recent filings connect the profile to Cartesian Therapeutics, Inc. (RNAC). The current snapshot covers public activity from Oct 28, 2025 to Jan 6, 2026. Reported amounts are shown as $128.4K to $442.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.